Administration of second dose of SARS-CoV-2 virus-like particle antigen vaccine
Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (procedure)
procedure
Supplier: international · SCTID 1179497009
Also known as (13)
- Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen
- Second dose of 2019 novel coronavirus virus-like particle antigen immunisation
- Second dose of 2019 novel coronavirus virus-like particle antigen immunization
- Second dose of 2019 novel coronavirus virus-like particle antigen vaccination
- Second dose of 2019-nCoV virus-like particle antigen immunisation
- Second dose of 2019-nCoV virus-like particle antigen immunization
- Second dose of 2019-nCoV virus-like particle antigen vaccination
- Second dose of COVID-19 virus-like particle antigen immunisation
- Second dose of COVID-19 virus-like particle antigen immunization
- Second dose of COVID-19 virus-like particle antigen vaccination
- Second dose of SARS-CoV-2 virus-like particle antigen immunization
- Second dose of SARS-CoV-2 virus-like particle antigen vaccination
- Second dose of severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccination